tiprankstipranks

Robert Lorne Hopfner Insider Profile

11 Followers
Robert Lorne Hopfner, Director at Hyperion Therapeutics, holds 0.00 shares in Hyperion Therapeutics (Ticker: HPTX), holds 1.57M shares in Inozyme Pharma (Ticker: INZY), holds 2.27M shares in Rallybio (Ticker: RLYB). Most recently, Robert Lorne Hopfner ― shares of Hyperion Therapeutics on ― for an estimated value of ―.
tipranks
Robert Lorne Hopfner

Robert Lorne Hopfner
Hyperion Therapeutics (HPTX)
Director

Ranked #27,438 out of 97,944 Corporate Insiders

Profitable Transactions

38%
3 out of 8 Profitable Transactions

Average Return

+4.70%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$145M
93.06%
4.84%
2.10%
A breakdown of Robert Lorne Hopfner's holdings

Insider Roles

Vaxcyte
(PCVX)
Director
Inozyme Pharma
(INZY)
Director
Rallybio
(RLYB)
Director
Roles that Robert Lorne Hopfner holds in companies

Most Profitable Insider Trade

Stock:
Inozyme Pharma
(INZY)
Rating:Informative Buy
Date:Mar 30, 2023 - Mar 30, 2024
Return:+63.30%
The most profitable trade made by Robert Lorne Hopfner

Robert Lorne Hopfner's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
HPTX
Hyperion Therapeutics
Vaxcyte
Feb 04, 2021
Director
Uninformative Sell
427.07K
$134.72M
Inozyme Pharma
Aug 03, 2023
Director
Informative Buy
4.00M
$7.01M
Rallybio
Aug 04, 2021
Director
Uninformative Buy
$3.04M
List of latest transactions for each holding click on a transaction to see Robert Lorne Hopfner's performance on stock

Robert Lorne Hopfner insider profile FAQ

What is the percentage of profitable transactions made by Robert Lorne Hopfner?
The percentage of profitable transactions made by Robert Lorne Hopfner is 38%.
    What is the average return per transaction made by Robert Lorne Hopfner?
    The average return per transaction made by Robert Lorne Hopfner is 4.70%.
      What stocks does Robert Lorne Hopfner hold?
      Robert Lorne Hopfner holds: HPTX, PCVX, INZY, RLYB stocks.
        What was Robert Lorne Hopfner’s latest transaction?
        Robert Lorne Hopfner latest transaction was an Uninformative Buy of ―.
          What was Robert Lorne Hopfner's most profitable transaction?
          Robert Lorne Hopfner’s most profitable transaction was an Informative Buy of INZY stock on March 30, 2023. The return on the trade was 63.30%.
            What is Robert Lorne Hopfner's role in Hyperion Therapeutics?
            Robert Lorne Hopfner's role in Hyperion Therapeutics is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.